IRIS
GITTO, Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.710
EU - Europa 13.414
AS - Asia 6.656
SA - Sud America 2.196
Continente sconosciuto - Info sul continente non disponibili 366
AF - Africa 196
OC - Oceania 12
Totale 43.550
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.431
RU - Federazione Russa 7.073
SG - Singapore 2.823
BR - Brasile 1.886
CN - Cina 1.663
IE - Irlanda 1.569
SE - Svezia 1.335
IT - Italia 698
VN - Vietnam 676
UA - Ucraina 614
HK - Hong Kong 605
DE - Germania 573
GB - Regno Unito 384
FR - Francia 378
FI - Finlandia 313
IN - India 301
CA - Canada 130
AR - Argentina 111
BD - Bangladesh 92
PL - Polonia 75
MX - Messico 72
IQ - Iraq 67
JP - Giappone 64
CZ - Repubblica Ceca 61
NL - Olanda 60
BE - Belgio 58
AT - Austria 53
ZA - Sudafrica 52
EC - Ecuador 51
TR - Turchia 51
MA - Marocco 47
ES - Italia 38
UZ - Uzbekistan 38
CI - Costa d'Avorio 33
CO - Colombia 31
ID - Indonesia 29
CL - Cile 27
VE - Venezuela 26
PK - Pakistan 25
PY - Paraguay 21
SA - Arabia Saudita 20
AE - Emirati Arabi Uniti 17
UY - Uruguay 17
JO - Giordania 16
EG - Egitto 15
GR - Grecia 15
IR - Iran 15
JM - Giamaica 15
AZ - Azerbaigian 14
PE - Perù 14
PH - Filippine 14
LT - Lituania 13
LV - Lettonia 13
MY - Malesia 13
OM - Oman 12
BO - Bolivia 11
NO - Norvegia 11
AL - Albania 10
KE - Kenya 10
NP - Nepal 10
RO - Romania 10
CR - Costa Rica 9
DO - Repubblica Dominicana 9
HN - Honduras 9
IL - Israele 9
KZ - Kazakistan 9
DZ - Algeria 8
KR - Corea 8
LB - Libano 8
PA - Panama 8
KG - Kirghizistan 7
NZ - Nuova Zelanda 7
PS - Palestinian Territory 7
PT - Portogallo 7
SK - Slovacchia (Repubblica Slovacca) 7
TN - Tunisia 7
AM - Armenia 6
CH - Svizzera 6
NI - Nicaragua 6
TT - Trinidad e Tobago 6
AU - Australia 5
GT - Guatemala 5
LK - Sri Lanka 5
MD - Moldavia 5
SN - Senegal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
DK - Danimarca 4
ET - Etiopia 4
GE - Georgia 4
HU - Ungheria 4
IS - Islanda 4
LU - Lussemburgo 4
RS - Serbia 4
TH - Thailandia 4
AO - Angola 3
BH - Bahrain 3
BY - Bielorussia 3
CY - Cipro 3
EE - Estonia 3
Totale 43.142
Salva come PNG Salva come JPEG
Città #
Dallas 10.077
Moscow 2.023
Dublin 1.567
Singapore 1.557
Ashburn 1.526
Chandler 1.189
Jacksonville 1.140
Nyköping 862
Beijing 619
Hong Kong 600
San Jose 542
Council Bluffs 406
Dong Ket 358
Los Angeles 313
The Dalles 257
Princeton 254
Dearborn 244
Lauterbourg 228
Cambridge 215
Medford 211
Des Moines 190
Messina 180
Ann Arbor 158
Boardman 150
Hyderabad 125
São Paulo 123
Buffalo 118
New York 114
Munich 109
Ho Chi Minh City 107
Woodbridge 89
Lancaster 86
Hanoi 80
Columbus 72
Guangzhou 72
Wilmington 69
Tianjin 68
Pune 64
Santa Clara 64
Orem 62
Brooklyn 56
Warsaw 56
Redondo Beach 55
Brussels 53
Frankfurt am Main 53
San Mateo 53
Turku 52
Belo Horizonte 50
Jinan 50
Milan 50
Seattle 50
Rio de Janeiro 49
Tokyo 49
Brno 43
Chicago 42
Vienna 42
Denver 41
Shenyang 41
Catania 39
Houston 39
Atlanta 38
Phoenix 38
Tashkent 38
London 37
Montreal 37
Johannesburg 36
Rome 36
Brasília 34
Abidjan 33
Amsterdam 33
Nanjing 31
Baghdad 30
Shanghai 29
Stockholm 29
Chennai 28
Haikou 28
Helsinki 28
Curitiba 27
Washington 27
Manchester 26
Nuremberg 26
Toronto 25
Porto Alegre 24
Guayaquil 22
Hangzhou 21
Poplar 21
San Francisco 21
Taizhou 21
Zhengzhou 21
Boston 20
Dhaka 19
Düsseldorf 19
Fuzhou 19
Lappeenranta 19
Ningbo 19
Ottawa 18
Ribeirão Preto 18
Fortaleza 17
Francofonte 17
Goiânia 17
Totale 28.298
Salva come PNG Salva come JPEG
Nome #
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: synthesis and stereochemistry 4.735
[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines: stereochemistry and anticonvulsant activity 4.715
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 302
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: non-competitive AMPA receptors antagonists 275
1-Aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamide derivatives: synthesis and biological evaluation 272
1,4-benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice 261
Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors 259
Inhibition of HIV-1 RT activity by a new series of 3-(1,3,4-thiadiazol-2-yl)thiazolidin-4-one derivatives 234
1-Benzylpiperidine derivatives: design and synthesis of new compounds as tyrosinase inhibitors from Agaricus bisporus 227
4-Fluorobenzylpiperazine-Containing Derivatives as Efficient Inhibitors of Mushroom Tyrosinase 218
4,5-Dihydro-7,8-dimethoxy-1-phenyl-3H-2,3-benzodiazepin-4-one 213
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 212
Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases 207
AMPA receptor antagonists: Synthesis and pharmacological evaluation 205
Exploiting the 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors as anti-melanogenic agents: Design, synthesis, structural insights and biological profile 204
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments 203
Anticonvulsant agent: enhancement of physicochemical properties 202
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 201
5-Phenyl-9H-1,3-dioxolo[4,5-h][2,3]-benzodiazepin-8(7H)-one 198
Computational methods to analyze and predict the binding mode of inhibitors targeting both human and mushroom tyrosinase 194
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 194
A Combination of Pharmacophore and Docking-based Virtual Screening to Discover new Tyrosinase Inhibitors 193
Seeking new approach for therapeutic treatment of cholera disease via inhibition of bacterial carbonic anhydrases: experimental and theoretical studies for sixteen benzenesulfonamide derivatives 192
P158-DEVELOPMENT OF FLEXIBLE ARYLSULFONAMIDES AS POTENTIAL MULTITARGET ANTICANCER AGENTS 192
5H-[1,2,4]OXADIAZOLO[5,4-D][1,5]BENZOTHIAZEPINES - SYNTHESIS AND STEREOCHEMISTRY 191
4-[1-(4-Fluorobenzyl)-4-hydroxy-1H-indol-3-yl]-2-hydroxy-4-oxobut-2-enoic acid as a prototype to develop dual inhibitors of HIV-1 integration process. 191
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety 190
Looking toward the Rim of the Active Site Cavity of Druggable Human Carbonic Anhydrase Isoforms 190
Identification of Potent and Selective Human Carbonic Anhydrase VII (hCA VII) Inhibitors 187
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 187
Discovery of benzimidazole-based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis 185
3D Pharmacophore model and synthesys of NMDA receptor subunit NR2B antagonists 184
Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms 184
Design and optimization of isoquinoline-sulfonamides as potent and selective inhibitors of human carbonic anhydrase VII 183
Discovery of a new potent inhibitor of mushroom tyrosinase (Agaricus bisporus) containing 4-(4-hydroxyphenyl)piperazin-1-yl moiety 183
4-Sulfamoylphenylalkylamides as Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 183
A structure-based approach to ligand discovery for inhibition of HIV-1 IN-LEDGF/p75 interaction: a new target for anti-AIDS therapy 182
Design and synthesis of acetylcholinesterase inhibitors 179
Synthesis and biochemical evaluation of 5-(pyridin-4-yl)-4H-1,2,4-triazol-4-amine-based inhibitors of tyrosinase from Agaricus bisporus 178
2,3-Benzodiazepines as potential AMPA receptors antagonists 173
A new potential approach to block HIV-1 replication via protein–protein interaction and strand-transfer inhibition 173
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson’s disease 172
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4 '-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists 170
HIV-1 integrase strand-transfer inhibitors: Design, synthesis and molecular modeling investigation 170
7,9-Dihydro-1,3-dioxolo[4,5-h][2,3]benzodiazepin-8(7H)-ones as anticonvulsant agents 169
In Silico-Guided Identification of New Potent Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae 168
7,11b-dihydro-9,10-dimethoxy-3,11b- diphenyl[1,2,4]oxadiazolo[5,4-a]-[2,3]benzodiazepin-6(5H)-one 167
Analysis of structure-activity relationships in a series of 4-(1-piperazinyl)phenol-based derivatives as competitive inhibitors of Tyrosinase 167
Antiretroviral strategy using multi-target agents 166
3D Pharmacophore Models for 1,2,3,4-Tetrahydroisoquinoline Derivatives Acting as Anticonvulsant Agents 166
Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor. 164
Identification of isoquinoline-sulfonamides as potent and selective carbonic anhydrase inhibitors 164
DISCOVERY OF NEW INDOLE DERIVATES AS NEUROPROTECTIVE AGENTS 164
Synthesis and biological evaluation of sulfonamide-based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae 163
In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules 163
Evaluation of 4-(4-Fluorobenzyl)piperazin-1-yl]-Based Compounds as Competitive Tyrosinase Inhibitors Endowed with Antimelanogenic Effects 163
Combined strategies for the discovery of ionotropic glutamate receptor antagonists 162
Discovery of potent and selective inhibitors of druggable carbonic anhydrase isoforms 162
2-Acetil-1-(4'-clorofenil)-6,7-dimetossi-1,2,3,4-tetraidroisochinolina (Ps3Ac) Potente AMPA-antagonista: Definizione del Profilo Enantiofarmacobiologico 161
Anticonvulsant activity and plasma level of 2,3-benzodiazepin- 4-ones (CFMs) in genetically epilepsy-prone rats 160
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as Potent Carbonic Anhydrase Inhibitors: Synthesis, Biological Evaluation, and Enzyme−Ligand X-ray Studies 159
Design, synthesis and in vitro evaluation of 4-fluorobenzyl- and 4-hydroxyphenyl-based compounds targeting tyrosinases 159
Novel Potent Anticonvulsant Agent Containing a Tetrahydroisoquinoline Skeleton. 158
3D pharmacophore model and the synthesis of NMDA receptor subunit NR2B antagonists 158
From NMDA receptor antagonists to discovery of selective σ2 receptor ligands 157
Leveraging the 3-Chloro-4-fluorophenyl Motif to Identify Inhibitors of Tyrosinase from Agaricus bisporus 156
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 156
Binding modes of noncompetitive AMPA antagonists: a computational approach 156
Antiretroviral strategy: design and synthesis of HIV-1 IN-LEDGF/p75 interaction inhibitors 155
Nuovi selettivi inibitori dell'anidrasi carbonica: sintesi, SAR e studi sull'interazione enzima/inibitore 155
Searching for indole derivatives as potential mushroom tyrosinase inhibitors 155
Nuovi ligandi del recettore NR2B/NMDA a struttura indolica 154
Synthesis and structure-active relationship of 1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline anticonvulsants 152
Binding mode investigation and SAR studies of HIV-1 integrase inhibitors 152
Annelated 1,5-benzothiazepines 152
ANNELATED 1,5-BENZODIAZEPINES .1. 3-MEMBERED, 4-MEMBERED, AND 5-MEMBERED RINGS. 151
Synthesis of new pyridazine derivatives as potential anti-HIV-1 agents 150
INVESTIGATION ON PYRIDINYL-1,2,4-TRIAZOLE-BASED COMPOUNDS AS -SYN AGGREGATION INHIBITORS FOR TREATING PARKINSON’S DISEASE 150
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 149
ANNELATED 1,5-BENZODIAZEPINES .2. 6 MEMBERED RINGS 149
Structural optimization and in vitro evaluation of new 1-(4-fluorobenzyl)piperazine derivatives as inhibitors of Tyrosinase from Agaricus bisporus 149
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL’INTEGRASI DELL’HIV-1 148
Small Molecules Targeting Protein–Protein Interactions: A Promising Anti-HIV Strategy 148
ELECTRONIC-PROPERTIES OF THIENODIAZEPINE AND BENZODIAZEPINE DERIVATIVES 147
Probing the molecular interactions between the human Carbonic Anhydrases (hCAs) and a novel class of benzenesulfonamides 147
Serendipitous discovery of indole derivatives as potent tyrosinase inhibitors 145
Searching for alpha-syn inhibitors to fight Parkinson’s disease 145
Exploring the chemical space of 3-chloro-4-fluorophenyl-based compounds as tyrosinase inhibitors 144
Ligand-Based Discovery of a Small Molecule as Inhibitor of α-Synuclein Amyloid Formation 143
Exploring the MUC1/CIN85 interaction to investigate a small library of peptide inhibitors as potential anti-metastatic agents 143
Computational Studies to Discover a New NR2B/NMDA Receptor Antagonist and Evaluation of Pharmacological Profile 142
PROGETTAZIONE E SINTESI DI NUOVI DKA ANALOGHI COME POTENZIALI INIBITORI DELL'INTEGRASI DELL'HIV-1 141
Discovery and optimization of isoquinoline-derived inhibitors of human Carbonic Anhydrases (hCAs) 141
Nuovi Antagonisti Noncompetitivi del Recettore AMPA a struttura tetraidroisochinolinica, 140
Discovery of HIV-1 Integrase and cellular cofactor LEDGF/p75 interaction inhibitors 140
PROGETTAZIONE E SINTESI DI NUOVI DERIVATI ISOCHINOLINICI COME AGENTI ANTICONVULSIVANTI MULTITARGET 139
The 1-(4-fluorobenzyl)piperazine fragment for the development of novel tyrosinase inhibitors 139
Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase 137
Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides. 137
Discovery of a novel class of Tyrosinase inhibitors as antimelanogenic agents 137
Totale 26.507
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.291
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.558 0 201 32 66 64 30 135 59 38 79 320 534
2022/20234.717 368 418 208 423 348 464 94 242 1.912 16 168 56
2023/20241.343 94 189 81 253 107 235 20 64 5 155 23 117
2024/20255.302 83 103 124 311 248 150 149 1.203 1.297 318 493 823
2025/202624.731 733 3.519 7.511 1.313 1.281 3.676 1.817 1.959 1.875 599 244 204
2026/2027771 230 541 0 0 0 0 0 0 0 0 0 0
Totale 43.550